search
Back to results

Effect of Arm Ergometry on Children With Down Syndrome

Primary Purpose

EFFECT OF ARM ERGOMETRY ON RESPIRATION

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
ARMEROMTERY
Sponsored by
Badr University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for EFFECT OF ARM ERGOMETRY ON RESPIRATION

Eligibility Criteria

10 Years - 14 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • comprehend and follow directions
  • AGE 10-14

Exclusion Criteria:

Anomalies of the vasculature.

-Participating in sports of any kind. Moderate to severe asthma

Sites / Locations

  • Hanaa

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

EXPERMINTAL GROUP

CONTROL GROUP

Arm Description

start with cycle at a pace of 15-25 cycles per minute without resistance and end with cycle 45cycles per minute

selected respiratory exercise program

Outcomes

Primary Outcome Measures

Discovery Spirometer
measure forced expiratory volume, the means incresed mean improvement
Discovery spirometer
Measure peak volume,the means incresed mean improvement

Secondary Outcome Measures

Full Information

First Posted
September 7, 2021
Last Updated
February 13, 2022
Sponsor
Badr University
search

1. Study Identification

Unique Protocol Identification Number
NCT05068570
Brief Title
Effect of Arm Ergometry on Children With Down Syndrome
Official Title
The Effects of Arm Ergometry Training on Pulmonary Function in Children With Down Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
February 2022
Overall Recruitment Status
Completed
Study Start Date
June 1, 2021 (Actual)
Primary Completion Date
September 10, 2021 (Actual)
Study Completion Date
September 30, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Badr University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Cardiopulmonary issues are the major cause of sickness and hospitalisation in children with Down syndrome . Down syndrome children are also more likely to develop chronic lung infections, middle ear infections, and persistent tonsillitis.
Detailed Description
30 Down's syndrome children (boys and girls). randomly separated into two groups of equal size. Both groups received traditional chest physical therapy, with the addition of arm ergometry training in Group B

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
EFFECT OF ARM ERGOMETRY ON RESPIRATION

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
EXPERMINTAL GROUP
Arm Type
Experimental
Arm Description
start with cycle at a pace of 15-25 cycles per minute without resistance and end with cycle 45cycles per minute
Arm Title
CONTROL GROUP
Arm Type
No Intervention
Arm Description
selected respiratory exercise program
Intervention Type
Other
Intervention Name(s)
ARMEROMTERY
Intervention Description
ARMERGOMTERY TRAINING FOR UPPERLIMB
Primary Outcome Measure Information:
Title
Discovery Spirometer
Description
measure forced expiratory volume, the means incresed mean improvement
Time Frame
pre and post treatment for 14 weeks at 3 times per week.
Title
Discovery spirometer
Description
Measure peak volume,the means incresed mean improvement
Time Frame
Pre and post treatment for 14 weeks at 3 times per week

10. Eligibility

Sex
All
Minimum Age & Unit of Time
10 Years
Maximum Age & Unit of Time
14 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: comprehend and follow directions AGE 10-14 Exclusion Criteria: Anomalies of the vasculature. -Participating in sports of any kind. Moderate to severe asthma
Facility Information:
Facility Name
Hanaa
City
Cairo
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effect of Arm Ergometry on Children With Down Syndrome

We'll reach out to this number within 24 hrs